← Back to Search

Radiofrequency-Based treatment

Radiofrequency Treatment for Skin Conditions

N/A
Recruiting
Led By Noori Kim
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
For HS patients, participants will have localized disease to the axillae, mild to moderate severity and no evidence of active infection as assessed by the investigator
Be older than 18 years old
Must not have
Participants on immune modulators
Participants with bleeding disorders
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new way to treat skin conditions using radiofrequency waves.

Who is the study for?
This trial is for adults aged 22-70 with mild to moderate Hidradenitis Suppurativa (HS) localized to the underarms, or healthy individuals. Participants must understand the study and follow procedures, including multiple skin biopsies. Excluded are those on certain medications like blood thinners, immune modulators, systemic steroids; with allergies to anesthetics; active infections; significant medical history; pregnant/nursing women; or a history of severe scarring.
What is being tested?
The study tests radiofrequency-based treatment's effects on human skin in HS patients and healthy subjects. It aims to determine if this method is feasible by observing how it affects treated areas compared to untreated ones.
What are the potential side effects?
Potential side effects may include reactions at the biopsy site such as pain, swelling, bruising or infection. There might also be risks associated with radiofrequency treatment itself like burns or changes in skin sensation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have HS with localized disease in my armpits, of mild to moderate severity, and no active infections.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently taking medication to modulate my immune system.
Select...
I have a bleeding disorder.
Select...
I have had keloids or thick scars in the last 10 years.
Select...
I currently have an active infection or am being treated for one.
Select...
I haven't taken any medication that could affect wound healing in the last year.
Select...
I have conditions that make electrothermolysis unsafe for me.
Select...
I am unable to understand and give consent for treatment.
Select...
I am currently taking systemic steroids.
Select...
I am taking blood thinners.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Safety of skin-RF interactions in axillary skin
Tolerability of skin-RF interactions in axillary skin

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Healthy ParticipantsExperimental Treatment1 Intervention
Electrothermolysis treatment using varying levels of RF energies

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,327 Previous Clinical Trials
14,874,760 Total Patients Enrolled
Noori KimPrincipal InvestigatorJohns Hopkins University

Media Library

Radiofrequency-Based treatment (Radiofrequency-Based treatment) Clinical Trial Eligibility Overview. Trial Name: NCT05066113 — N/A
Hidradenitis Suppurativa Research Study Groups: Healthy Participants
Hidradenitis Suppurativa Clinical Trial 2023: Radiofrequency-Based treatment Highlights & Side Effects. Trial Name: NCT05066113 — N/A
Radiofrequency-Based treatment (Radiofrequency-Based treatment) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05066113 — N/A
~9 spots leftby Aug 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top